Keyphrases
Dendrimer
55%
Polyamidoamine (PAMAM)
22%
Clinical Development
22%
Design Development
20%
Fluorescence Detection
20%
N-acetylcysteine
20%
Therapeutic Targeting
20%
Amyloid Fibrils
20%
Metabolic Homeostasis
20%
Small Interfering RNA (siRNA)
20%
Glioblastoma
20%
Medulloblastoma
20%
Peptide Conjugates
20%
Topical Administration
20%
Reversible Self-assembly
20%
Engineered Peptide
20%
Acyl-CoA Synthetase Long-chain Family Member 4 (ACSL4)
20%
Eye Drops
20%
Targeted Intracellular Delivery
20%
Preclinical Development
20%
Thixotropic Properties
20%
Clinic Design
20%
Hyperexcitable
20%
Gelation Method
20%
MicroRNA-211
20%
Human Sperm
20%
Retinal Ganglion Cells
20%
Virus Infection
20%
Neurological Disorders
20%
Targeted Dendrimer
20%
MicroRNA
20%
PS19 Mice
20%
Nanomedicine
20%
Hydroxyl
20%
Semen
20%
Drug Discovery
13%
Severe COVID-19
13%
Delivery System
11%
Posterior Segment
10%
Covalent Connection
10%
Neuroprotection
10%
Non-aromatic
8%
Drug Substance
6%
Hyperinflammation
6%
Clinical Work
6%
N-acetylcysteine Conjugate
6%
Clinical Trials
6%
Hospitalized Adults
6%
Activated Microglia
6%
Potential Treatments
6%
Pharmacology, Toxicology and Pharmaceutical Science
Dendrimer
100%
Disease
40%
Drug Conjugate
40%
Melanin
30%
Poly(amidoamine)
28%
Nanoparticle
26%
Mouse Model
25%
Mouse
21%
Prostate Cancer
20%
Alisertib
20%
Ocular Drug
20%
Eye Disease
20%
Glioblastoma
20%
Amino Acid
20%
Small Interfering RNA
20%
Brimonidine
20%
Arginine
20%
Acetylcysteine
20%
Cell Culture
20%
Naphthalene
20%
Dipeptide
20%
Neurologic Disease
20%
Nanomedicine
20%
Ribonucleoprotein
20%
Neuroprotection
16%
Combination Therapy
14%
Alzheimer's Disease
13%
Cytotoxicity
12%
Neoplasm
11%
Sustained Release
10%
Optic Nerve Injury
10%
Rat Model
10%
Chronic Disease
10%
Sunitinib
10%
Cell Penetrating Peptide
10%
Therapeutic Window
10%
Antibody Drug Conjugate
7%
Fluorescence Activated Cell Sorting
6%
Pilocarpine
6%
Integrin
6%
Anticonvulsive Agent
6%
Excitotoxicity
6%
Ethylene Glycol
6%
Traumatic Brain Injury
6%
Transgenic Mouse
6%
Brain Disease
6%
Sodium Valproate
6%
Primary Culture
6%
Drug Discovery
6%
Fibronectin
6%